Alnylam Pharmaceuticals (ALNY) CFO reports stock award, sale transactions
Rhea-AI Filing Summary
Alnylam Pharmaceuticals executive Jeffrey V. Poulton, EVP and Chief Financial Officer, reported equity award vesting and related share sales. On January 11, 2026, he received 6,193 shares of common stock at $0.0 upon vesting of 40% of a performance-based stock unit granted on March 1, 2024, after the company reported $2.5 billion in annual net product revenue under GAAP. On January 12, 2026, the company automatically sold multiple small blocks of Poulton’s shares, coded as sales, under a mandatory sell-to-cover provision to satisfy minimum statutory tax withholding, at weighted average prices described in ranges from $353.53 to $374.89. Following these transactions, Poulton directly held 57,465 Alnylam shares and indirectly held 57 shares through a managed account, and the footnotes note additional shares acquired via the issuer’s 401(k) matching contribution program.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 72 | $353.95 | $25K |
| Sale | Common Stock | 78 | $355.16 | $28K |
| Sale | Common Stock | 76 | $356.09 | $27K |
| Sale | Common Stock | 176 | $357.17 | $63K |
| Sale | Common Stock | 226 | $358.18 | $81K |
| Sale | Common Stock | 156 | $359.14 | $56K |
| Sale | Common Stock | 284 | $360.22 | $102K |
| Sale | Common Stock | 181 | $361.45 | $65K |
| Sale | Common Stock | 135 | $362.38 | $49K |
| Sale | Common Stock | 87 | $363.55 | $32K |
| Sale | Common Stock | 365 | $364.83 | $133K |
| Sale | Common Stock | 405 | $365.56 | $148K |
| Sale | Common Stock | 92 | $366.41 | $34K |
| Sale | Common Stock | 76 | $367.40 | $28K |
| Sale | Common Stock | 170 | $368.62 | $63K |
| Sale | Common Stock | 73 | $369.48 | $27K |
| Sale | Common Stock | 36 | $370.87 | $13K |
| Sale | Common Stock | 6 | $372.46 | $2K |
| Sale | Common Stock | 25 | $374.44 | $9K |
| Sale | Common Stock | 34 | $375.65 | $13K |
| Sale | Common Stock | 27 | $377.82 | $10K |
| Grant/Award | Common Stock | 6,193 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- On March 1, 2024, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of forty (40) percent of the shares subject to the PSU based on the issuer publicly reporting $2.5 billion in annual net product revenue in accordance with GAAP, as determined by the People, Culture and Compensation Committee of the Issuer Board of Directors on January 11, 2026. Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $353.53 to $354.41. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $354.54 to $355.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.62 to $356.61. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.63 to $357.63. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $357.68 to $358.68. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $358.69 to $359.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $359.79 to $360.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $360.90 to $361.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $361.93 to $362.92. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $362.99 to $363.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $364.00 to $365.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $365.01 to $366.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $366.03 to $366.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $367.04 to $368.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $368.09 to $369.08. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $369.13 to $369.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $370.43 to $371.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $372.35 to $372.50. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $374.08 to $374.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
FAQ
What insider activity did ALNY report for Jeffrey V. Poulton?
ALNY reported that EVP and Chief Financial Officer Jeffrey V. Poulton received 6,193 shares of common stock from a vested performance-based stock unit on January 11, 2026, followed on January 12, 2026 by multiple small sales of shares.
What performance goal triggered the vesting of the ALNY PSU award?
The shares vested after Alnylam publicly reported $2.5 billion in annual net product revenue in accordance with GAAP, with this achievement determined by the People, Culture and Compensation Committee on January 11, 2026.